Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Anaptysbio (ANAB) over the last 9 years, with Q3 2025 value amounting to $0.52.

  • Anaptysbio's EPS (Weighted Average and Diluted) rose 14561.4% to $0.52 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.76, marking a year-over-year increase of 5460.53%. This contributed to the annual value of -$5.12 for FY2024, which is 1583.86% up from last year.
  • Anaptysbio's EPS (Weighted Average and Diluted) amounted to $0.52 in Q3 2025, which was up 14561.4% from -$1.34 recorded in Q2 2025.
  • In the past 5 years, Anaptysbio's EPS (Weighted Average and Diluted) ranged from a high of $0.52 in Q3 2025 and a low of -$1.71 during Q2 2024
  • For the 5-year period, Anaptysbio's EPS (Weighted Average and Diluted) averaged around -$1.05, with its median value being -$1.19 (2021).
  • As far as peak fluctuations go, Anaptysbio's EPS (Weighted Average and Diluted) crashed by 724257.58% in 2022, and later skyrocketed by 14561.4% in 2025.
  • Anaptysbio's EPS (Weighted Average and Diluted) (Quarter) stood at -$1.19 in 2021, then surged by 33.96% to -$0.79 in 2022, then crashed by 102.32% to -$1.59 in 2023, then surged by 51.73% to -$0.77 in 2024, then surged by 167.75% to $0.52 in 2025.
  • Its last three reported values are $0.52 in Q3 2025, -$1.34 for Q2 2025, and -$1.28 during Q1 2025.